Literature DB >> 9950752

Thymic microenvironments, 3-D versus 2-D?

W van Ewijk1, B Wang, G Hollander, H Kawamoto, E Spanopoulou, M Itoi, T Amagai, Y F Jiang, W T Germeraad, W F Chen, Y Katsura.   

Abstract

Lympho-stromal interactions in the thymus crucially de- termine the fate of developing T cells. Epithelial cells, inter- digitating reticular cells, macrophages and fibroblasts all play a role in the shaping of the T cell repertoire. Recently published evidence shows that lympho-stromal interaction acts bi-directional. Developing T cell themselves, at different stages of differentiation, control the microarchitecture of thymic microenvironments, a phenomenon designated as 'crosstalk'. This paper reviews experiments showing that developing T cells crosstalk to different thymic epithelial cells in a stepwise fashion. In this way, correctly organized thymic microenvironments guarantee normal thymopoiesis. Copyright 1999 Academic Press.

Mesh:

Year:  1999        PMID: 9950752     DOI: 10.1006/smim.1998.0158

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  35 in total

1.  Microenvironmental reprogramming of thymic epithelial cells to skin multipotent stem cells.

Authors:  Paola Bonfanti; Stéphanie Claudinot; Alessandro W Amici; Alison Farley; C Clare Blackburn; Yann Barrandon
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

2.  Bioengineering Thymus Organoids to Restore Thymic Function and Induce Donor-Specific Immune Tolerance to Allografts.

Authors:  Yong Fan; Asako Tajima; Saik Kia Goh; Xuehui Geng; Giulio Gualtierotti; Maria Grupillo; Antonina Coppola; Suzanne Bertera; William A Rudert; Ipsita Banerjee; Rita Bottino; Massimo Trucco
Journal:  Mol Ther       Date:  2015-04-23       Impact factor: 11.454

Review 3.  Mechanisms of thymus organogenesis and morphogenesis.

Authors:  Julie Gordon; Nancy R Manley
Journal:  Development       Date:  2011-09       Impact factor: 6.868

4.  Identification and characterization of thymus LIM protein: targeted disruption reduces thymus cellularity.

Authors:  J Kirchner; K A Forbush; M J Bevan
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

5.  Restoration of Thymus Function with Bioengineered Thymus Organoids.

Authors:  Asako Tajima; Isha Pradhan; Massimo Trucco; Yong Fan
Journal:  Curr Stem Cell Rep       Date:  2016-06

6.  The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease.

Authors:  Il-Kang Na; Sydney X Lu; Nury L Yim; Gabrielle L Goldberg; Jennifer Tsai; Uttam Rao; Odette M Smith; Christopher G King; David Suh; Daniel Hirschhorn-Cymerman; Lia Palomba; Olaf Penack; Amanda M Holland; Robert R Jenq; Arnab Ghosh; Hien Tran; Taha Merghoub; Chen Liu; Gregory D Sempowski; Melissa Ventevogel; Nicole Beauchemin; Marcel R M van den Brink
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

7.  DKK1 mediated inhibition of Wnt signaling in postnatal mice leads to loss of TEC progenitors and thymic degeneration.

Authors:  Masako Osada; Logan Jardine; Ruth Misir; Thomas Andl; Sarah E Millar; Mark Pezzano
Journal:  PLoS One       Date:  2010-02-08       Impact factor: 3.240

8.  Individual and overlapping roles of BH3-only proteins Bim and Bad in apoptosis of lymphocytes and platelets and in suppression of thymic lymphoma development.

Authors:  P N Kelly; M J White; M W Goschnick; K A Fairfax; D M Tarlinton; S A Kinkel; P Bouillet; J M Adams; B T Kile; A Strasser
Journal:  Cell Death Differ       Date:  2010-04-30       Impact factor: 15.828

9.  Lymphoid EVA1 expression is required for DN1-DN3 thymocytes transition.

Authors:  Stefano Iacovelli; Ilaria Iosue; Silvia Di Cesare; Maria Guttinger
Journal:  PLoS One       Date:  2009-10-23       Impact factor: 3.240

10.  A cellular automata-based mathematical model for thymocyte development.

Authors:  Hallan Souza-e-Silva; Wilson Savino; Raúl A Feijóo; Ana Tereza Ribeiro Vasconcelos
Journal:  PLoS One       Date:  2009-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.